Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with ...
CD Formulation, a leading force in biotechnology research and development, is at the forefront of revolutionizing transdermal delivery systems. As the demand for non-invasive, efficient drug delivery ...
The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe ...
This technology can be incorporated into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. Nutriband’s lead product under ...
(MENAFN- GlobeNewsWire - Nasdaq) The AVERSATM transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 ...
This technology can be incorporated into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. Nutriband’s lead product under ...
The AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents already issued in 46 countries including the United States, Europe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback